Liz Szabo

Liz Szabo was a senior correspondent for KFF Health News until December 2023.

@LizSzabo

Scientists Warn Americans Are Expecting Too Much From a Vaccine

KFF Health News Original

Some argue that vaccines capable of preventing any COVID-19 symptoms should qualify for widespread use, but others want much larger trials to prove the vaccines can reduce hospitalizations or deaths.

Signs of an ‘October Vaccine Surprise’ Alarm Career Scientists

KFF Health News Original

President Donald Trump has the legal power to authorize a COVID vaccine over the objections of the Food and Drug Administration and vaccine manufacturers. Such a move could further erode public trust in a vaccine and foist an unsafe shot on Americans.

NIH ‘Very Concerned’ About Serious Side Effect in Coronavirus Vaccine Trial

KFF Health News Original

The AstraZeneca trial is on hold in the U.S. as scientists try to unravel whether a rare neurological condition is linked to the vaccine. But regulators are frustrated by a lack of information from the drugmaker.

Health Officials Worry Nation’s Not Ready for COVID-19 Vaccine

KFF Health News Original

As the nation awaits a vaccine to end the pandemic, local health departments say they lack the staff, money, tools ― and a unified plan ― to distribute, administer and track millions of vaccines, most of which will require two doses. Dozens of doctors, nurses and health officials interviewed by KHN and The Associated Press expressed their concern and frustration over federal shortcomings.

Fractured Skulls, Lost Eyes: Police Often Break Own Rules Using ‘Rubber Bullets’

KFF Health News Original

Around the country, police responded to protests in the wake of George Floyd’s death by shooting “less lethal” projectiles, which can seriously hurt and kill. In a joint investigation, KHN and USA TODAY found some officers appear to have violated their department’s own rules when they fired.

ICUs Become A ‘Delirium Factory’ For COVID Patients

KFF Health News Original

The coronavirus that causes COVID-19 targets more than just the lungs. New research shows it also penetrates the brain, complicating treatment and risking lifelong damage. And the pandemic limits hospitals from running MRIs or other tests on coronavirus patients.